Series E funding round for Antiva Biosciences raising $53M in April 2023
Series E funding round for Antiva Biosciences raising $53M in April 2023
| Investor | Firm Type | Partner |
|---|
MPM CapitalLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 6 funding rounds. Current round is highlighted.
Total Raised
$138.3M
Top Valuation
-
Antiva Biosciences raised $53M in a Series E round.
The round was announced on 04/01/23.
The round was led by Florencia Segal.